Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Clinical Performance of Senofilcon A Investigational Lens
NCT05300763 · View on ClinicalTrials.gov ↗
Study Summary
This study is a controlled, randomized, subject-masked, 2-arm parallel, 2-week dispensing, bilateral evaluation where the study lenses are worn for a minimum of 5 days per week and 6 hours per day.
Conditions Studied
Interventions
- DEVICE senofilcon A prototype
- DEVICE Dailies Total 1
Study Locations (19)
Florida
- Vue Optical Boutique — Jacksonville
- Dr. James Weber & Associates, PA - City Square Blvd — Jacksonville
- Stam & Associates Eye Care — Jacksonville
- Sabal Eye Care — Longwood
- Maitland Vision Center - North Orlando Ave — Maitland
- Flora Chen Poveda, OD, PA - Orange Park — Orange Park
- Southwest Orlando Eye Care — Orlando
- Tallahassee Eye Center — Tallahassee
Tennessee
- Optometry Group, LLC — Memphis
- Total Eye Care — Memphis
California
- Randall Go, OD — San Francisco
Georgia
- VisualEyes — Roswell
Kansas
- Kannarr Eye Care — Pittsburg
Michigan
- Birmingham Vision Care — Bloomfield
New York
- Sacco Eye Group — Vestal
Ohio
- ProCare Vision Centers — Granville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2022-03-21 |
| Est. Completion | 2022-05-25 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05300763
The ClinicalTrials.gov registry entry for NCT05300763 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 344 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 36 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions — of which senofilcon A prototype is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05300763 reports 19 study locations spanning 11 distinct geographic areas — top geographies include Florida, Tennessee, California. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05300763 about?
NCT05300763 is a clinical study titled "Clinical Performance of Senofilcon A Investigational Lens". This study is a controlled, randomized, subject-masked, 2-arm parallel, 2-week dispensing, bilateral evaluation where the study lenses are worn for a minimum of 5 days per week and 6 hours per day.
What is the current status of trial NCT05300763?
This trial is currently completed. It is a NA study. The enrollment target is 344 participants. The study started on 2022-03-21. Estimated completion is 2022-05-25.
What conditions does trial NCT05300763 study?
This clinical trial studies the following conditions: Visual Acuity. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05300763?
The interventions under investigation include: senofilcon A prototype (DEVICE), Dailies Total 1 (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05300763?
This trial is sponsored by Johnson & Johnson Vision Care, which has 36 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05300763 being conducted?
This trial has 19 study locations across California, Florida, Georgia, Kansas, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.